Skip to main content
. 2018 Aug 9;109(9):2852–2862. doi: 10.1111/cas.13724

Figure 4.

Figure 4

Maximum percent change from baseline in tumor size in patients with non‐small‐cell lung cancer treated with ASP8273 (phase I, local review)